Clinical trial

Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne…

NCT00280657 · Bayer, Industry · Completed

Key facts

NCT number NCT00280657
Title Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa
Official title Multicenter, Double-blind, Double-dummy, Randomized Parallel Group Study to Evaluate the Safety and Efficacy of SH D 00659 E for 6 Treatment Cycles in Female Patients With Acne Papulopustulosa in Comparison to SH D 00659 G and Placebo.
Lead sponsor Bayer, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Acne Vulgaris
Intervention type Drug
Interventions Valette, Diane, Placebo
Enrollment 1,326
Start date Mar 10, 2004
Primary completion May 21, 2005
Completion May 21, 2005
First posted Jan 23, 2006
Last update posted Jun 6, 2023
Countries Czechia, Poland, Russia, Slovakia, Ukraine

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies